- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | GETINGE: Fluorecence imaging - a game-changer for endocrine surgery in German university hospital | 4 | Cision News | ||
| Di | Getinge's production facility in Halland is now powered by 99.9 percent renewable energy | 2 | Cision News | ||
| 17.06. | Bernstein initiates Getinge stock coverage with Market Perform rating | 6 | Investing.com | ||
| 24.04. | Dividendenbekanntmachungen (24.04.2025) | 12.705 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0127 EUR ALPHA GROUP INTERNATIONAL PLC GB00BF1TM596 0,14 GBP 0,1638 EUR AQ GROUP AB SE0022062196 1... ► Artikel lesen | |
| 22.04. | Getinge AB: Resolutions at Getinge's Annual General Meeting April 22, 2025 | 291 | GlobeNewswire (Europe) | Press Release
Gothenburg, Sweden on April 22, 2025
Getinge AB (publ)'s Annual General Meeting ("AGM") was held on April 22, 2025 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the... ► Artikel lesen | |
| 22.04. | Getinge AB: Getinge Interim Report January-March 2025: Strong sales and improved earnings - continued focus on customer value and profitability going forward | 286 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on April 22, 2025
"We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects," says Mattias... ► Artikel lesen | |
| GETINGE AB ADR Aktie jetzt für 0€ handeln | |||||
| 22.04. | Getinge AB Non-GAAP EPS of €0.46, revenue of €520.1M; initiates FY25 outlook | 3 | Seeking Alpha | ||
| 08.04. | Getinge invites fund managers, analysts, and media to Q1 Report 2025 conference call | 4 | Cision News | ||
| 27.03. | Getinge publishes Annual Report for 2024 | 347 | PR Newswire | GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes... ► Artikel lesen | |
| 24.03. | Federal court revives Getinge heart pump patent suit against J&J's Abiomed | 8 | MassDevice | ||
| 20.03. | Embracing Getinge's purpose | 3 | Cision News | ||
| 18.03. | Getinge introduces Neural Pressure Support for the Servo-u ventilator system | 11 | Cision News | ||
| 13.03. | NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL) | 4 | Cision News | ||
| 11.03. | Getinge's Nomination Committee proposes Ulrika Dellby as new Board member | 4 | Cision News | ||
| 27.02. | Getinge's new DPTE[®]-FLEX Alpha port enables gloveless component transfer, minimizing human intervention and contamination risks in pharmaceutical production | 5 | Cision News | ||
| 30.01. | Getinge to phase out its surgical perfusion business | 31 | MassDevice | ||
| 28.01. | Getinge shares surge on strong Q4, beats expectations across the board | 6 | Investing.com | ||
| 28.01. | Getinge AB Non-GAAP EPS of SEK 5.28, revenue of SEK 11.07B; initiates FY25 outlook | 4 | Seeking Alpha | ||
| 28.01. | Getinge AB: Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins | 930 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on January 28, 2025
"In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly,... ► Artikel lesen | |
| 14.01. | Getinge invites fund managers, analysts, and media to Year-End Report 2024 conference call | 20 | Cision News |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 48,300 | +0,52 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
| ESSILORLUXOTTICA | 233,70 | -0,38 % | BERNSTEIN RESEARCH stuft EssilorLuxottica auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für EssilorLuxottica auf "Market-Perform" mit einem Kursziel von 245 Euro belassen. Luca Solca befasste sich in... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 159,75 | -0,81 % | Reasons to Add Align Technology Stock to Your Portfolio Now | ||
| INMODE | 12,345 | +1,73 % | InMode Ltd.: InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 | YOKNEAM, Israel, May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent... ► Artikel lesen | |
| ELEVANCE HEALTH | 319,70 | -1,90 % | Dividendenbekanntmachungen (25.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASYMCHEM LABORATORIES TIANJIN CO LTD CNE100004Z06 1,2021 HKD 0,1319 EUR BANK FIRST CORPORATION US06211J1007 0,45 USD 0,3875 EUR BENETEAU... ► Artikel lesen | |
| TENET | 146,00 | -1,35 % | Tenet Healthcare upgraded to BB- by S&P on improved performance | ||
| BONESUPPORT | 25,760 | 0,00 % | Bonesupport Holding AB: Upcoming CEO change. Emil Billbäck will transfer to a role as Senior Advisor. Torbjörn Sköld will start as CEO effective September 1st, 2025 | BONESUPPORT, a leading company in orthobiologics for the management of bone injuries, today announces the coming transition of leadership at Bonesupport.
Lennart Johansson states: Emil Billbäck will... ► Artikel lesen | |
| ARJO | 3,052 | -0,97 % | Arjo announces date for 2025 Q2 and conference call | ||
| AMN HEALTHCARE SERVICES | 16,700 | -1,18 % | AMN Healthcare Services Inc: Celia Huber Joins AMN Healthcare Board of Directors | ||
| OSSDSIGN | 1,200 | -0,83 % | OssDsign AB: OssDsign announces remarkable real-world results with 88.4% fusion rate in a highly complex patient cohort from the spinal fusion registry PROPEL | Uppsala, June 26, 2025. OssDsign AB (publ.) today announces that the company has published one-year results from the first 108 patients in its prospective, multi-center, spinal fusion registry PROPEL.... ► Artikel lesen | |
| CHECK-CAP | 0,645 | -4,44 % | MediPharm Labs Corp.: MediPharm Labs Cautions Shareholders about Dissident Nominees' Governance Failures at Check-Cap Ltd. | TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm", the "Company", or "we"), a pharmaceutical company specialized in precision-based cannabinoids, today provided... ► Artikel lesen | |
| ALPHATEC | 9,132 | -3,22 % | Alphatec Holdings, Inc. Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook | CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary... ► Artikel lesen | |
| FISHER & PAYKEL HEALTHCARE | 18,500 | +0,54 % | Dividendenbekanntmachungen (23.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AECON GROUP INC CA00762V1094 0,19 CAD 0,12 EUR ARROWMARK FINANCIAL CORP US8617801043 0,45 USD 0,3905 EUR ASSECO POLAND SA PLSOFTB00016 3... ► Artikel lesen | |
| CROSS COUNTRY HEALTHCARE | 11,300 | +2,73 % | CROSS COUNTRY HEALTHCARE INC - 10-Q, Quarterly Report | ||
| STEREOTAXIS | 1,850 | 0,00 % | Stereotaxis, Inc.: Stereotaxis Reports 2025 First Quarter Financial Results | ST. LOUIS, May 12, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results... ► Artikel lesen |
GETINGE AB ADR gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -0,61 % bei einem Aktienkurs von 16,300 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GETINGE AB ADR finden Sie auf Wallstreet Online.